EMA denies adaptive licensing project 'slowing or closing down'; calls for more applications
This article was originally published in SRA
Executive Summary
The European Medicines Agency said yesterday it wanted to quash a rumor that its in-demand adaptive licensing pilot project was slowing or closing down. "We are very much open to further submissions" from drug companies that want to take part in the initiative, a UK regulator involved in the pilot said.